Financhill
Sell
27

ELV Quote, Financials, Valuation and Earnings

Last price:
$383.05
Seasonality move :
2.51%
Day range:
$378.98 - $385.38
52-week range:
$362.21 - $567.26
Dividend yield:
1.71%
P/E ratio:
13.88x
P/S ratio:
0.51x
P/B ratio:
2.02x
Volume:
1.2M
Avg. volume:
1.8M
1-year change:
-20.68%
Market cap:
$88.3B
Revenue:
$171.3B
EPS (TTM):
$27.43

Earnings Data

Next earnings date for ELV
Jan 24
2025
Most recent earnings per share
$4.36
Missed by $5.29
(Oct 17/2024)
Consensus Estimate
$9.65
(Oct 17/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ELV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $45.1B -- -- $10.20 --
01/24/2025 Q4 $44.5B -- -- $3.87 --
10/17/2024 Q3 $43.1B $45.1B $4.36 $9.65 -$5.29
07/17/2024 Q2 $42.9B $43.6B $9.85 $10.01 -$0.16
04/18/2024 Q1 $42.4B $42.6B $9.59 $10.53 -$0.94
01/24/2024 Q4 $42.2B $42.6B $3.63 $5.59 -$1.96
10/18/2023 Q3 -- -- $5.45 $8.46 -$3.01
07/19/2023 Q2 -- -- $7.79 $8.77 -$0.98
04/19/2023 Q1 -- -- $8.30 $9.28 -$0.98
01/25/2023 Q4 -- -- $3.93 $5.19 -$1.26
10/19/2022 Q3 -- -- $6.62 $7.15 -$0.53
07/20/2022 Q2 -- -- $6.73 -- --
04/20/2022 Q1 -- -- $7.32 -- --
12/31/2021 Q4 -- -- $4.63 -- --
09/30/2021 Q3 -- -- $6.13 -- --
06/30/2021 Q2 -- -- $7.25 -- --
03/31/2021 Q1 -- -- $6.71 -- --
12/31/2020 Q4 -- -- $2.19 -- --
09/30/2020 Q3 -- -- $0.87 -- --
06/30/2020 Q2 -- -- $8.91 -- --
03/31/2020 Q1 -- -- $5.94 -- --
12/31/2019 Q4 -- -- $3.62 -- --
09/30/2019 Q3 -- -- $4.55 -- --
06/30/2019 Q2 -- -- $4.36 -- --
03/31/2019 Q1 -- -- $5.91 -- --
12/31/2018 Q4 -- -- $1.61 -- --
09/30/2018 Q3 -- -- $3.62 -- --
06/30/2018 Q2 -- -- $3.98 -- --
03/31/2018 Q1 -- -- $4.99 -- --
12/31/2017 Q4 -- -- $4.67 -- --
09/30/2017 Q3 -- -- $2.80 -- --
06/30/2017 Q2 -- -- $3.16 -- --
03/31/2017 Q1 -- -- $3.73 -- --
12/31/2016 Q4 -- -- $1.37 -- --
09/30/2016 Q3 -- -- $2.30 -- --
06/30/2016 Q2 -- -- $2.91 -- --
03/31/2016 Q1 -- -- $2.63 -- --
12/31/2015 Q4 -- -- $0.68 -- --
09/30/2015 Q3 -- -- $2.43 -- --
06/30/2015 Q2 -- -- $3.13 -- --
03/31/2015 Q1 -- -- $3.09 -- --

Elevance Health Earnings Questions

  • How Much did Elevance Health Generate in Revenue Last Quarter?

    Elevance Health reported $45.1B worth of top line sales in its most recent quarter.

  • Did Elevance Health Beat Earnings Last Quarter?

    Elevance Health announced earnings per share of $4.36 which represents a miss of analyst forecast a $9.65 per share.

  • Is Elevance Health Profitable?

    Elevance Health reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Elevance Health EPS Next Year?

    Elevance Health's earnings are forecast to grow from $25.22 per share to $32.97 per share next year representing an increase of 30.97%.

  • When is Elevance Health's Earnings Date?

    Elevance Health's next earnings date is January 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Disney vs Estée Lauder Stock, Which Is Best?
Disney vs Estée Lauder Stock, Which Is Best?

Inflation has eaten away at a lot of the money…

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is down 0.23% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 4.97% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 8.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock